• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number JHJR052502J
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Thrombosis (2100)
Event Date 09/01/2018
Event Type  Injury  
Manufacturer Narrative
Date of event: device thrombosis occurred one month post initial implant procedure ((b)(6) 2018).Since the exact date of event cannot be identified, (b)(6) 2018 will be determined as the date of event.A review of the manufacturing records for the device could not be conducted as lot number of the reported device was not available.According to the gore® viabahn® endoprosthesis instructions for use (ifu), device- and/or procedure-related complications and adverse events include, but are not limited to thrombosis or occlusion.
 
Event Description
On (b)(6) 2018, the patient underwent endovascular repair of an occlusive lesion in the left superficial femoral artery and was implanted with non-gore manufactured bare-metal stent and a gore® viabahn® endoprosthesis (jhjr052502j with an unknown lot number).The patient tolerated the procedure.One month post initial implant procedure, the patient admitted to the hospital due to claudication.An ultrasonography was run, confirming that the existing gore® viabahn® endoprosthesis had occluded.On (b)(6) 2018, a reintervention was performed to treat the endoprosthesis occlusion.Pre-procedure angiography was run, confirming thrombosis from the proximal end of the bare-metal stent to the distal end of the gore® viabahn® endoprosthesis.Thrombectomy was performed and non-gore manufactured vascular stents were implanted inside the gore® viabahn® endoprosthesis.Thrombus partially remained, so plain old balloon angioplasty (poba) was further performed.Thrombus still existed inside the endoprosthesis, but the physician elected to monitor the patient and completed the reintervention procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
yutaka uchiya
1500 n. 4th street
9285263030
MDR Report Key8036573
MDR Text Key126067284
Report Number2017233-2018-00660
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/01/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/05/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberJHJR052502J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age60 YR
-
-